Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- CPP (children):
- 1600 µg/day (2 sprays [400 µg] into each nostril AM + 2 sprays each nostril PM = 8 sprays/day)
- May increase to 1800 µg/day if inadequate suppression
- Continue until resumption of puberty desired
- Endometriosis (women ≥18 y):
- 400 µg/day (1 spray [200 µg] into one nostril AM + 1 spray into other nostril PM)
- Maximum 6 months; retreatment not recommended
- Start between cycle days 2-4
- Route: Intranasal spray only